Drug Trial Radar · NCT00121524
Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome
Last checked: Nov 20, 2026Latest source record: May 29, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
904
Actual
Start
Jan 2003
Primary completion
May 2008
Study completion Jun 2008
Sponsor
- Lead sponsor
- Petter Andreas SteenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Laerdal Medical; Ullevaal University Hospital; Health Region East, Norway; Norwegian Air Ambulance Foundation; University of Oslo
- First posted
- Jul 21, 2005
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation since the start. It improves outcome in animal studies, but has never been investigated in a controlled study in humans. Epidemiologic data indicate that it is an independent negative predictor for survival. If this is true in a controlled randomized study, it could be due to effects of the drug itself or more likely due to reduced quality of chest compressions and ventilations due to the time spent on placing an I.V. needle and injecting drugs.
Conditions
- Cardiac Arrest
Interventions
EpinephrineDrug
Epinephrine 1 mg is given iv. every 3 min during CPR
Intravenous needleDevice
An intravenous needle in placed as soon as possible during CPR
AtropineDrug
Atropine 3 mg iv in initial systole
AmiodaroneDrug
amiodarone 300 mg iv after repeated failed defibrillation attempts
Primary outcomes
What the sponsor says the trial is designed to measure.
- survival to hospital discharge with neurologic outcomeTime frame: discharge from hospital
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ulleval University Hospital
Oslo, Norway
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.